News
The evolution of diabetes technologies has led to the expansion of automated insulin delivery for type 2 diabetes, continuous ...
Achieved the ADA targets of HbA1c <7% and time in range of >70%. Were free of SHEs from day 90 onwards. Had a reduction in exogenous insulin use (mean reduction in daily insulin dose: 92%).
Altimmune, Inc.'s Pemvidutide shows promise in MASH treatment with liver improvements and safety, despite market overreaction. Click for my ALT stock update.
XRP/USD daily price chart. Source: TradingView The gains are part of a broader consolidation cycle after XRP’s 575% price boom since November. Can XRP’s price go higher from the current levels?
Get instant access to a free live Bitcoin Real-Time streaming chart. The chart is intuitive yet powerful, customize the chart type to view candlestick patterns, area, line graph style, bar chart ...
The full IcoSema dose was 700U/mL icodec plus 2 mg/mL semaglutide, titrated up from 40 U icodec and 0.114 mg semaglutide. The primary endpoint was the change in glycated hemoglobin (HbA 1c) from ...
If you have type 2 diabetes, exercise is an important habit that can help you manage your blood sugar levels. Find out the best exercises for type 2 diabetes.
As Cointelegraph reported, a move to new all-time highs above $112,000 would be possible by the end of this week if the resistance at the 50-day SMA ($105,000) is flipped into new support.
Oral semaglutide was associated with more pronounced cardiovascular benefits among patients with higher baseline HbA1c in ...
All 3 doses of orforglipron superior to placebo with respect to primary end point of change in HbA1c from baseline to week 40.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results